Arcutis Sale Purchase Of Stock from 2010 to 2024

ARQT Stock  USD 12.69  0.44  3.59%   
Arcutis Biotherapeutics Sale Purchase Of Stock yearly trend continues to be comparatively stable with very little volatility. Sale Purchase Of Stock will likely drop to about 10.7 M in 2024. From the period from 2010 to 2024, Arcutis Biotherapeutics Sale Purchase Of Stock quarterly data regression had r-value of  0.16 and coefficient of variation of  156.48. View All Fundamentals
 
Sale Purchase Of Stock  
First Reported
2010-12-31
Previous Quarter
11.2 M
Current Value
10.7 M
Quarterly Volatility
25.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Arcutis Biotherapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arcutis Biotherapeutics' main balance sheet or income statement drivers, such as Interest Expense of 31.2 M, Selling General Administrative of 182.2 M or Total Revenue of 62.6 M, as well as many indicators such as Price To Sales Ratio of 3.57, Dividend Yield of 0.0 or PTB Ratio of 2.65. Arcutis financial statements analysis is a perfect complement when working with Arcutis Biotherapeutics Valuation or Volatility modules.
  
Check out the analysis of Arcutis Biotherapeutics Correlation against competitors.
For more information on how to buy Arcutis Stock please use our How to Invest in Arcutis Biotherapeutics guide.

Latest Arcutis Biotherapeutics' Sale Purchase Of Stock Growth Pattern

Below is the plot of the Sale Purchase Of Stock of Arcutis Biotherapeutics over the last few years. It is Arcutis Biotherapeutics' Sale Purchase Of Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arcutis Biotherapeutics' overall financial position and show how it may be relating to other accounts over time.
Sale Purchase Of Stock10 Years Trend
Pretty Stable
   Sale Purchase Of Stock   
       Timeline  

Arcutis Sale Purchase Of Stock Regression Statistics

Arithmetic Mean16,563,823
Geometric Mean7,881,389
Coefficient Of Variation156.48
Mean Deviation16,395,914
Median7,069,000
Standard Deviation25,919,051
Sample Variance671.8T
Range93.9M
R-Value0.16
Mean Square Error704.6T
R-Squared0.03
Significance0.57
Slope936,344
Total Sum of Squares9405.2T

Arcutis Sale Purchase Of Stock History

202410.7 M
202311.2 M
202212.5 M
2021842 K
2020617 K
201994.5 M
201861.6 M

About Arcutis Biotherapeutics Financial Statements

Arcutis Biotherapeutics shareholders use historical fundamental indicators, such as Sale Purchase Of Stock, to determine how well the company is positioned to perform in the future. Although Arcutis Biotherapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Arcutis Biotherapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Arcutis Biotherapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Sale Purchase Of Stock11.2 M10.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Arcutis Stock Analysis

When running Arcutis Biotherapeutics' price analysis, check to measure Arcutis Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcutis Biotherapeutics is operating at the current time. Most of Arcutis Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Arcutis Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcutis Biotherapeutics' price. Additionally, you may evaluate how the addition of Arcutis Biotherapeutics to your portfolios can decrease your overall portfolio volatility.